License from Helmholtz Munich will enable progression of brain cancer treatment
A treatment for one of the most aggressive and difficult to treat cancers is the…
A treatment for one of the most aggressive and difficult to treat cancers is the…
Evonik has entered into a long-term supply agreement with Phathom Pharmaceuticals, a U.S. biopharma company…
This week, we have three interviews. Our guests are: Pam Putz, managing director of EBD…
Swedish biotech company Oncopeptides AB has initiated the commercial launch of Pepaxti (melphalan flufenamide) in…
ESPG AG – European Science Park Group – is one of the first German real…
Overfishing is a global issue that negatively impacts the ecosystem and our access to fish…
A company developing agonists that stimulate immune cells today (September 26) announced it has secured…
The first and only approved treatment for primary immunoglobin A (IgA) nephropathy, a rare, progressive…
Sigma-Aldrich Co LLC, along with genOway, a preclinical research model space company, announced today (September…
Dutch biotech Synaffix B.V. and German Emergence Therapeutics announced today (September 6) they have entered…
Scientists at the Fraunhofer Institute for Translational Medicine and Pharmacology ITMP in Germany are working…
In the past few months, Labiotech.eu has boosted its coverage range to go global, added…